𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis

✍ Scribed by Dr. Harry J. Iland; John Laszlo; Delvyn C. Case Jr.; Scott Murphy; Thomas A. Reichert; C. Y. Tso; Louis R. Wasserman


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
644 KB
Volume
25
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis


Myeloproliferative Subcommittee of the Polycythemia Vera Study Group

Accurate distinction between essential thrombocythemia and thrombocytotic polycythemia Vera requires determination of the red cell mass in the presence of adequate iron stores, but this is not always possible. We therefore compared the clinical and laboratory features at the time of presentation of 50 patients with unequivocal essential thrombocythemia and 27 patients with thrombocytotic polycythemia Vera. Univariate analysis failed to identify any single parameter capable of reliably separating the groups. A logistic regression algorithm incorporating hematocrit, white cell count, and spleen size markedly increased the diagnostic accuracy (92%) compared with predictions based on the hematocrit alone (52%). The algorithm's usefulness for patients with intermediate hematocrits was confirmed by analysis of independent samples of essential thrombocythemia and thrombocytotic polycythemia Vera patients, and also by analysis of patients with probable essential thrombocythemia in whom the diagnosis could not be confirmed because of inadequate exclusion of polycythemia Vera. Furthermore, comparison of survival data suggests that differentiating these disorders is prognostically important. The algorithm is recommended as an alternate method for differentiating essential thrombocythemia from thrombocytotic polycythemia Vera whenever the red cell mass is unavailable or iron deficiency cannot be excluded.


πŸ“œ SIMILAR VOLUMES


Ξ±-2a interferon therapy and antibody for
✍ E. TΓΆrnebohm-Roche; M. Merup; D. Lockner; Dr. C. Paul πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 479 KB πŸ‘ 1 views

In ten patients with essential thrombocythemia and polycythemia Vera with thrombocytosis we have investigated the therapeutic effect of recombinant a-2a interferon (Roceron-A@) given subcutaneously in a maintenance dosage of 3 million units three times weekly. The aim was to normalize the platelet

Genetic lesions associated with blastic
✍ Gianluca Gaidano; Cristina Pastore; Valeria Santini; Josep Nomdedeu; Barbara Gam πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 2 views

Polycythemia vera (PV) and essential thrombocythemia (ET) are chronic myeloproliferative disorders that may progress to acute leukemia in a subset of patients. This study aimed at investigating the genetic lesions associated with the blastic transformation of PV and ET. A panel of PV and ET cases at